ATA484978A - Verfahren zur herstellung von neuen prostaglandinderivaten - Google Patents

Verfahren zur herstellung von neuen prostaglandinderivaten

Info

Publication number
ATA484978A
ATA484978A AT484978A AT484978A ATA484978A AT A484978 A ATA484978 A AT A484978A AT 484978 A AT484978 A AT 484978A AT 484978 A AT484978 A AT 484978A AT A484978 A ATA484978 A AT A484978A
Authority
AT
Austria
Prior art keywords
prostagland
derivatives
producing new
producing
new
Prior art date
Application number
AT484978A
Other languages
English (en)
Other versions
AT363623B (de
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ATA484978A publication Critical patent/ATA484978A/de
Application granted granted Critical
Publication of AT363623B publication Critical patent/AT363623B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
AT0484978A 1977-07-05 1978-07-04 Verfahren zur herstellung von neuen prostaglandinderivaten AT363623B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/813,068 US4163016A (en) 1977-07-05 1977-07-05 16-Substituted prostaglandins
US06/027,589 US4212993A (en) 1977-07-05 1979-04-06 16-Substituted prostaglandins

Publications (2)

Publication Number Publication Date
ATA484978A true ATA484978A (de) 1981-01-15
AT363623B AT363623B (de) 1981-08-25

Family

ID=26702670

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0484978A AT363623B (de) 1977-07-05 1978-07-04 Verfahren zur herstellung von neuen prostaglandinderivaten

Country Status (10)

Country Link
US (2) US4163016A (de)
EP (1) EP0000207A1 (de)
JP (1) JPS5414945A (de)
AT (1) AT363623B (de)
AU (1) AU3751878A (de)
DE (1) DE2829331A1 (de)
FR (1) FR2396748A1 (de)
GB (1) GB2001311B (de)
NL (1) NL7807292A (de)
SE (1) SE7807544L (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228298A (en) * 1979-06-07 1980-10-14 American Cyanamid Company 15-Deoxy-16-hydroxy-16-fluoromethyl, difluoromethyl or trifluoromethyl prostaglandins of the E and F series
US5204371A (en) * 1979-12-10 1993-04-20 Schering Aktiengesellschaft Pharmaceutically active 9-chloroprostaglandins
DE2950027A1 (de) * 1979-12-10 1981-06-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin 9-chlor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US4738283A (en) 1986-05-08 1988-04-19 Matsushita Electric Industrial Co. Ltd. Gas flow controller
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
ATE78465T1 (de) * 1987-10-02 1992-08-15 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2322543A1 (fr) * 1973-01-08 1977-04-01 Cpc International Inc Nouvelle composition insecticide aqueuse applicable par pulverisation et son application a la lutte contre les insectes
US3959263A (en) * 1974-06-19 1976-05-25 American Home Products Corporation Prostaglandin intermediate
US4053467A (en) * 1974-07-03 1977-10-11 American Home Products Corporation Prostaglandin derivatives
GB1545633A (en) * 1975-02-24 1979-05-10 American Cyanamid Co 11-deoxy substituted prostaglandins of the e and f series
ZA764727B (en) * 1975-09-02 1977-07-27 Upjohn Co Prostanoic acid derivatives

Also Published As

Publication number Publication date
GB2001311B (en) 1982-03-31
GB2001311A (en) 1979-01-31
AU3751878A (en) 1980-01-03
US4163016A (en) 1979-07-31
JPS5414945A (en) 1979-02-03
FR2396748A1 (fr) 1979-02-02
AT363623B (de) 1981-08-25
SE7807544L (sv) 1979-03-07
EP0000207A1 (de) 1979-01-10
NL7807292A (nl) 1979-01-09
DE2829331A1 (de) 1979-01-25
US4212993A (en) 1980-07-15

Similar Documents

Publication Publication Date Title
AT367425B (de) Verfahren zur herstellung von neuen cephemderivaten
AT367426B (de) Verfahren zur herstellung von neuen cephemderivaten
AT362065B (de) Verfahren zur herstellung von neuen pleuromutilinglycosidderivaten
AT363182B (de) Verfahren zur herstellung von neuen cephemderivaten
AT357673B (de) Verfahren zur herstellung von neuen 9-amino- desoxyclavulansaeurederivaten
LU78919A1 (de) Verfahren zur herstellung von neuen aminoalkoxyphenyl-derivaten
AT365591B (de) Verfahren zur herstellung von neuen indolderivaten
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
ATA472577A (de) Verfahren zur herstellung von neuen 1-acyl-4- -hydroxy-imidazol-5-carboxamid-derivaten
AT362368B (de) Verfahren zur herstellung von neuen oxazolidin- 2-on-derivaten
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT363623B (de) Verfahren zur herstellung von neuen prostaglandinderivaten
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT371109B (de) Verfahren zur herstellung von neuen benzolsulfonamidderivaten
AT365203B (de) Verfahren zur herstellung von neuen 9-fluorprednisolon-derivaten
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT371119B (de) Verfahren zur herstellung von neuen sulfoximid-derivaten
ATA678178A (de) Verfahren zur herstellung von neuen fluorhaltigen prostaglandinderivaten
AT365610B (de) Verfahren zur herstellung von neuen 19-nor-10cyano-peruvosid-derivaten
AT363473B (de) Verfahren zur herstellung von neuen 4-hydroxy-thiazolidin-2-thion-derivaten
ATA532778A (de) Verfahren zur herstellung von neuen 19-norpregnahexaenderivaten
ATA86679A (de) Verfahren zur herstellung von neuen cis-4a-phenyl-isochinolinderivaten
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
AT359517B (de) Verfahren zur herstellung von neuen alfa- -halogenaethylcarbamidsaeurehalogeniden
AT361920B (de) Verfahren zur herstellung von neuen benzo- pyranoxanthenderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee